Cellular-scale boron distribution in tumour and normal tissue
45No. 899 in all physics · No. 43 in Medical and Radiation Physics
Measure the B-10 concentration distribution at 1 to 10 micron resolution in tumour, tumour margin and normal tissue for the clinical carriers (boronophenylalanine and sodium borocaptate), including the fraction of tumour cells with low uptake, and convert it into a microdosimetric specific-energy distribution for the $\alpha$ and Li-7 fragments of ranges about 9 and 5 micron. An answer is a measured distribution and the resulting ratio of cellular to bulk-averaged dose.
What would settle it
Neutron autoradiography or secondary-ion mass spectrometry on biopsy samples taken at treatment time, combined with track-level dose calculation.
No solutions, ideas or subproblems yet.
See also
- Related Biological weighting of the neutron capture mixed field
- Related Dose at the scale of nephrons and marrow cavities
Details, signature and history
- Kind
- Well-posed question
- Answer
- Value
- Topic review
- Suzuki, Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era, International Journal of Clinical Oncology, 2020. Link
- Record
- Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor
Proof
- Fingerprint
- d29436889344…
- Public log
- Entry 1,666, in checkpoint 2,123
- In the log by
- Block 969,698, 2026-10-03
This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.
Comments (0)
Comments are not records: they are not signed, stamped or logged. How comments work
No comments yet.
Sign in to comment.